Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome

Background: Neoadjuvant imatinib therapy has been proposed for routine practice with favorable long-term results for patients with locally advanced gastrointestinal stromal tumors (GISTs). However, clarification of the optimal duration, safety, and oncological outcomes of neoadjuvant imatinib use be...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shang-Yu, Wu, Chiao-En, Lai, Chun-Chi, Chen, Jen-Shi, Tsai, Chun-Yi, Cheng, Chi-Tung, Yeh, Ta-Sen, Yeh, Chun-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468640/
https://www.ncbi.nlm.nih.gov/pubmed/30934606
http://dx.doi.org/10.3390/cancers11030424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468640/
https://www.ncbi.nlm.nih.gov/pubmed/30934606
http://dx.doi.org/10.3390/cancers11030424

Ejemplares similares